Expert Rev Gastroenterol Hepatol. 2011;5(4):479-487. © 2011 Expert Reviews Ltd. Cite this: Clinical and Immunological Features of Celiac Disease in Patients With ...

Researchers from the TEDDY study highlight how specific genetic and environmental factors may drive early autoimmunity linked ...

researchers successfully induced T1DM, confirmed by significantly elevated fasting glucose levels. This model allowed for an in-depth examination of diabetes-induced changes in a controlled ...

Can type 1 diabetes be managed or cured? Yes! Breakthrough treatments like Donislecel and Teplizumab offer hope for better ...

Researchers at Fred Hutchinson Cancer Center, led by Dr. Julie McElrath, Director of the Vaccine and Infectious Disease Division, have found a new way to train our immune system to make antibodies ...

The progressive autoimmune destruction of pancreatic β cells characteristic of T1DM is widely believed ... a chimeric anti-CD20 monoclonal antibody developed to treat hematological neoplasias ...

Antivenom (often spelled “antivenin”) is an antibody product that can disable a particular venom’s toxins. If injected quickly after a bite or sting, the antibodies in antivenom neutralize the venom, ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. For example, an antibody that can recognise an antigen on the ...

Since 2001, research conducted by pediatric endocrinology faculty encompassed cystic fibrosis-related bone health/growth, treatment and etiology of type 1 diabetes (T1DM), lipoprotein ...

Serological screening for CD should be performed in all T1DM patients by means of antibodies to tissue transglutaminase at T1DM onset. T1DM patients found to be celiacs must be treated by a gluten ...

Antibodies bind to specific antigens on pathogens. This means that only one type of antibody will bind to a matching antigen. Scientists discovered that we could make antibodies to bind to ...